# The CBD Conversation – Insights for Chiropractic Economics > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cbd-clinical-practice-chiropractic-economics/ > **Published:** 2026-03-26T16:02:52-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:37:21-04:00 > **Clinical Summary:** Explore CBD clinical practice in chiropractic economics, focusing on evidence-based patient communication and pain management strategies. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic [Pain Management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/)Cbd[Clinical Practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/)Interdisciplinary CarePatient Communication Why This Matters Chiropractors increasingly encounter patients using CBD for [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/), yet many lack evidence-based frameworks for these conversations. This creates potential gaps in care coordination and missed opportunities for optimizing patient outcomes through informed guidance. Clinical Summary The integration of CBD discussions into chiropractic practice reflects broader healthcare trends as patients seek multimodal pain management approaches. While CBD shows promise for certain pain conditions, the evidence base remains limited with significant variability in product quality and dosing protocols. Chiropractors, like other healthcare providers, must navigate patient interest in CBD while maintaining evidence-based practice standards and appropriate scope of practice boundaries. Dr. Caplan’s Take “I see this as part of healthcare’s necessary evolution – patients are using CBD whether we discuss it or not, so we need structured approaches to these conversations. The key is distinguishing between what we know, what we suspect, and what remains unknown while maintaining our clinical credibility.” Clinical Perspective 🧠 Practitioners should develop consistent protocols for CBD discussions, including assessment of current use, potential drug interactions, and realistic expectations setting. Documentation of these conversations becomes important for continuity of care, and referral pathways to cannabis-knowledgeable physicians may be necessary for complex cases requiring medical oversight. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20CBD%20conversation%20-%20Chiropractic%20Economics%20%40drcaplan&url=https%3A//www.chiroeco.com/the-cbd-conversation/amp/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.chiroeco.com/the-cbd-conversation/amp/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20CBD%20conversation%20-%20Chiropractic%20Economics%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.chiroeco.com/the-cbd-conversation/amp/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.chiroeco.com/the-cbd-conversation/amp/](https://www.chiroeco.com/the-cbd-conversation/amp/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What medical applications does this research focus on?](#What_medical_applications_does_this_research_focus_on) - [Is this information relevant for current clinical practice?](#Is_this_information_relevant_for_current_clinical_practice) - [What type of healthcare approach does this research involve?](#What_type_of_healthcare_approach_does_this_research_involve) - [How current is this research information?](#How_current_is_this_research_information) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the findings represent emerging developments or policy changes that healthcare professionals should monitor closely. #### What medical applications does this research focus on? The research primarily focuses on pain management using CBD. It also examines [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/) applications and interdisciplinary care approaches involving [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). #### Is this information relevant for current clinical practice? Yes, this is tagged as having clinical practice relevance. The “Notable Clinical Interest” rating indicates these findings could influence current treatment approaches and warrant attention from practicing clinicians. #### What type of healthcare approach does this research involve? The research emphasizes interdisciplinary care approaches. This suggests the findings are relevant for multiple healthcare specialties working together in patient treatment rather than a single discipline. #### How current is this research information? This is marked as “New” research, indicating recently published or emerging findings. The classification as “emerging findings” suggests this represents the latest developments in cannabis [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/). {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “The CBD conversation – Chiropractic Economics”, “url”: “https://www.chiroeco.com/the-cbd-conversation/amp/”, “datePublished”: “2026-03-26T16:32:12Z”, “about”: “cbd conversation chiropractic economics”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence CBD Gummies News: What's Actually Worth Paying Attention To in 2026 Stay updated on the latest CBD gummies news and what matters most in 2026 for clinical practice. Read More The Science Behind Cannabis and Its [Therapeutic Benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) – NUG Magazine Explore the scientific evidence supporting cannabis [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) relevant to clinical practice. Explore Now [CBD shows promise, but this review warns the hype is outpacing the science](https://cedclinic.com/cbd-drug-interactions-epilepsy-clinical-evidence-safety/) Understand the balance between CBD promise and scientific evidence in clinical settings. [Learn More](https://cedclinic.com/cbd-drug-interactions-epilepsy-clinical-evidence-safety/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).